DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells ; volume:9 ; number:1 ; day:10 ; month:10 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (10.10.2009), 1-9, 12.2009
- Urheber
-
Unger, Florian T.
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/1471-2407-9-359
- URN
-
urn:nbn:de:1111-2016030352455
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Unger, Florian T.
- Klasen, Hermann A.
- Tchartchian, Garri
- de Wilde, Rudy L.
- Witte, Irene
- SpringerLink (Online service)
Ähnliche Objekte (12)
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Vergleich zweier neoadjuvanter Radiochemotherapien bei fortgeschrittenen Mundhöhlenkarzinomen : (Cis-Platin cersus Paclitaxel, Carboplatin)
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids
Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Vergleich zweier neoadjuvanter Radiochemotherapien bei fortgeschrittenen Mundhöhlenkarzinomen : (Cis-Platin cersus Paclitaxel, Carboplatin)
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids
Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Vergleich zweier neoadjuvanter Radiochemotherapien bei fortgeschrittenen Mundhöhlenkarzinomen : (Cis-Platin cersus Paclitaxel, Carboplatin)
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Carboplatin-induced gene expression changes in vitroare prognostic of survival in epithelial ovarian cancer
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids